Skip to main content

iTeos Therapeutics, Inc.

ITOSDelisted Aug 29, 2025
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001808865

iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by iTeos Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for iTeos Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for iTeos Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Rhoads Ann DDirector–Aug 29, 20250
Hallal DavidDirector0Aug 29, 20250
Gall MatthewChief Financial Officer0Aug 29, 20250
Detheux MichelChief Executive Officer0IndirectAug 29, 20250
Call MatthewChief Operating Officer0Aug 29, 20250
McGrath YvonneChief Scientific Officer0Aug 29, 20250
Lee David KDirector–Aug 29, 20250
Feltquate DavidChief Medical Officer0Aug 29, 20250
EcoR1 Capital, LLC10% Owner10,688,978IndirectMay 16, 20250
Gadicke AnsbertOther: Former 10% Owner3,452,797IndirectMay 15, 20250
MPM BioImpact LLCOther: Former 10% Owner3,452,797IndirectMay 15, 20250
UBS Oncology Impact Fund L.P.Other: Former 10% Owner3,452,797IndirectMay 15, 20250
Oncology Impact Fund (Cayman) Management L.P.Other: Former 10% Owner3,452,797IndirectMay 15, 20250
MPM Bioventures 2018, L.P.Other: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2018 GP LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2018 LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
Evnin LukeOther: Former 10% Owner2,108,594IndirectMay 15, 20250
Foley ToddOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2014, L.P.Other: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2014 (B), L.P.Other: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM Asset Management Investors BV2014 LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM Bioventures 2018 (B), L.P.Other: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM Asset Management Investors BV2018 LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2014 LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
MPM BioVentures 2014 GP LLCOther: Former 10% Owner2,108,594IndirectMay 15, 20250
Van Hauwermeiren TimothyDirector22,346May 14, 20250
Davis Aaron I.Director2,946,915Jun 13, 20240
Ho Tony WDirector–Jun 13, 20240
Iannone RobertDirector–Jun 13, 20240
DeSimone JillDirector–Jun 13, 20240
Lewis JosephOther: See remarks2,946,915May 14, 20240
Boxer Asset Management Inc.Other: See remarks2,946,915May 14, 20240
Boxer Capital, LLCOther: See remarks2,946,915May 14, 20240
RA Capital Healthcare Fund LPOther: Former 10% Owner2,545,510IndirectMay 14, 20240
Ra Capital Management, L.P.Other: Former 10% Owner2,545,510IndirectMay 14, 20240
Kolchinsky PeterOther: Former 10% Owner2,545,510IndirectMay 14, 20240
Shah Rajeev M.Other: Former 10% Owner2,545,510IndirectMay 14, 20240
DiRocco DerekDirector–Jun 15, 20230
Lager Joanne JenkinsChief Medical Officer0Mar 10, 20230
Biniszkiewicz DetlevDirector0Jun 10, 20220
Roden MatthewDirector–Jun 10, 20220
MVA Investors, LLC10% Owner0Jan 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 19, 2021 (view filing)Nov 181 dayLager Joanne JenkinsChief Medical OfficerSSale−28.0K$34.50−$966.0K−100.0%0 after
Nov 3, 2021 (view filing)Nov 1-32 daysDetheux MichelChief Executive OfficerSSale−20.6K$28.56−$587.1K−21.2%76.4K after3 lots
Oct 25, 2021 (view filing)Oct 214 daysDetheux MichelChief Executive OfficerSSale−196$28.00−$5.49K−0.2%97.0K after
Oct 19, 2021 (view filing)Oct 15-194 daysDetheux MichelChief Executive OfficerSSale−1.84K$28.01−$51.4K−1.9%97.2K after2 lots
Oct 18, 2021 (view filing)4:35 PM ETOct 15-183 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−17.1K$27.45−$469.3K−0.5%3.13M after3 lotsDuplicate filing
Oct 18, 2021 (view filing)4:34 PM ETOct 15-183 daysEvnin Luke and 8 others10% OwnerSSale−17.1K$27.45−$469.3K−0.5%3.13M after3 lots
Oct 18, 2021 (view filing)4:33 PM ETOct 15-183 daysGadicke Ansbert and 3 others10% OwnerSSale−28.6K$27.45−$785.4K−0.6%5.14M after3 lots
Oct 14, 2021 (view filing)5:28 PM ETOct 12-142 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−56.8K$27.21−$1.54M−1.8%3.15M after3 lotsDuplicate filing
Oct 14, 2021 (view filing)5:27 PM ETOct 12-142 daysEvnin Luke and 8 others10% OwnerSSale−56.8K$27.21−$1.54M−1.8%3.15M after3 lots
Oct 14, 2021 (view filing)5:26 PM ETOct 12-142 daysGadicke Ansbert and 3 others10% OwnerSSale−95.0K$27.21−$2.58M−1.8%5.17M after3 lots
Oct 12, 2021 (view filing)4:34 PM ETOct 7-115 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−52.0K$27.23−$1.42M−1.6%3.21M after3 lotsDuplicate filing
Oct 12, 2021 (view filing)4:34 PM ETOct 7-115 daysEvnin Luke and 8 others10% OwnerSSale−52.0K$27.23−$1.42M−1.6%3.21M after3 lots
Oct 12, 2021 (view filing)4:33 PM ETOct 7-115 daysGadicke Ansbert and 3 others10% OwnerSSale−87.0K$27.23−$2.37M−1.6%5.26M after3 lots
Oct 5, 2021 (view filing)4:33 PM ETOct 1-44 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−27.6K$27.05−$745.5K−0.8%3.26M after2 lotsDuplicate filing
Oct 5, 2021 (view filing)4:32 PM ETOct 1-44 daysEvnin Luke and 8 others10% OwnerSSale−27.6K$27.05−$745.5K−0.8%3.26M after2 lots
Oct 5, 2021 (view filing)4:31 PM ETOct 1-44 daysGadicke Ansbert and 3 others10% OwnerSSale−46.1K$27.05−$1.25M−0.9%5.35M after2 lots
Sep 30, 2021 (view filing)5:06 PM ETSep 28-302 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−21.5K$27.00−$580.7K−0.6%3.29M after2 lotsDuplicate filing
Sep 30, 2021 (view filing)5:06 PM ETSep 28-302 daysEvnin Luke and 8 others10% OwnerSSale−21.5K$27.00−$580.7K−0.6%3.29M after2 lots
Sep 30, 2021 (view filing)5:05 PM ETSep 28-302 daysGadicke Ansbert and 3 others10% OwnerSSale−36.0K$27.00−$971.7K−0.7%5.39M after2 lots
Sep 27, 2021 (view filing)5:52 PM ETSep 23-274 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−53.5K$27.76−$1.48M−1.6%3.31M after4 lotsDuplicate filing
Sep 27, 2021 (view filing)5:51 PM ETSep 23-274 daysEvnin Luke and 8 others10% OwnerSSale−53.5K$27.76−$1.48M−1.6%3.31M after4 lots
Sep 27, 2021 (view filing)5:51 PM ETSep 23-274 daysGadicke Ansbert and 3 others10% OwnerSSale−89.5K$27.76−$2.48M−1.6%5.43M after4 lots
Sep 27, 2021 (view filing)Sep 23-244 daysDetheux MichelChief Executive OfficerSSale−6.41K$28.14−$180.4K−6.1%99.0K after2 lots
Sep 23, 2021 (view filing)4:19 PM ETSep 21-222 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−33.9K$27.50−$933.0K−1.0%3.36M after2 lotsDuplicate filing
Sep 23, 2021 (view filing)4:19 PM ETSep 21-222 daysEvnin Luke and 8 others10% OwnerSSale−33.9K$27.50−$933.0K−1.0%3.36M after2 lots
Sep 23, 2021 (view filing)4:18 PM ETSep 21-222 daysGadicke Ansbert and 3 others10% OwnerSSale−56.8K$27.50−$1.56M−1.0%5.52M after2 lots
Sep 20, 2021 (view filing)6:38 PM ETSep 16-204 daysEvnin Luke and 8 others10% OwnerSSale−91.3K$28.38−$2.59M−2.6%3.40M after4 lotsDuplicate filing
Sep 20, 2021 (view filing)6:37 PM ETSep 16-204 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−91.3K$28.38−$2.59M−2.6%3.40M after4 lots
Sep 20, 2021 (view filing)6:30 PM ETSep 16-204 daysGadicke Ansbert and 3 others10% OwnerSSale−152.7K$28.38−$4.33M−2.7%5.58M after4 lots
Sep 16, 2021 (view filing)4:48 PM ETSep 14-152 daysEvnin Luke and 8 others10% OwnerSSale−45.7K$27.70−$1.26M−1.3%3.49M after4 lotsDuplicate filing
Sep 16, 2021 (view filing)4:46 PM ETSep 14-152 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−45.7K$27.70−$1.26M−1.3%3.49M after4 lots
Sep 16, 2021 (view filing)4:46 PM ETSep 14-152 daysGadicke Ansbert and 3 others10% OwnerSSale−76.4K$27.70−$2.12M−1.3%5.73M after4 lots
Sep 13, 2021 (view filing)7:02 PM ETSep 9-134 daysGadicke Ansbert and 3 others10% OwnerSSale−96.5K$28.32−$2.73M−1.6%5.81M after4 lots
Sep 13, 2021 (view filing)7:01 PM ETSep 9-134 daysEvnin Luke and 8 others10% OwnerSSale−57.6K$28.32−$1.63M−1.6%3.53M after4 lotsDuplicate filing
Sep 13, 2021 (view filing)6:59 PM ETSep 9-134 daysMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−57.6K$28.32−$1.63M−1.6%3.53M after4 lots
Sep 8, 2021 (view filing)7:19 PM ETSep 7-81 dayGadicke Ansbert and 3 others10% OwnerSSale−71.2K$29.03−$2.07M−1.2%5.90M after3 lots
Sep 8, 2021 (view filing)7:13 PM ETSep 7-81 dayEvnin Luke and 8 others10% OwnerSSale−42.6K$29.03−$1.24M−1.2%3.59M after3 lotsDuplicate filing
Sep 8, 2021 (view filing)7:12 PM ETSep 7-81 dayMPM Bioventures 2018, L.P. and 2 others10% OwnerSSale−42.6K$29.03−$1.24M−1.2%3.59M after3 lots
Sep 3, 2021 (view filing)Sep 1-22 daysDetheux MichelChief Executive OfficerSSale−20.3K$28.66−$580.5K−16.1%105.4K after3 lots
Aug 31, 2021 (view filing)Aug 27-314 daysDetheux MichelChief Executive OfficerSSale−14.7K$28.13−$412.5K−10.4%125.7K after3 lots
Aug 25, 2021 (view filing)Aug 23-252 daysDetheux MichelChief Executive OfficerSSale−8.59K$28.06−$240.9K−5.8%140.4K after3 lots